11 Years on TA-65: Honest Report on Telomerase Activation Medicine
1 month ago
- Telomere shortening may contribute to multiple age-related conditions.
Dr. Park explains that telomeres protect chromosome ends and shorten as cells divide. He presents the theory that telomere dysfunction and stem-cell aging may contribute to many conditions commonly viewed as separate diseases. - TA-65 and cycloastragenol are presented as telomerase activators.
The episode examines cycloastragenol, a compound derived from astragalus and marketed as a telomerase activator. Dr. Park discusses its proposed mechanism and shares personal and patient-reported experiences, while acknowledging that evidence remains limited. - Personal outcomes and anecdotes are not the same as clinical proof.
Although the discussion includes reports of improved sleep, energy, mood, recovery, and metabolic health, Dr. Park notes that cycloastragenol is sold as a supplement and has not been validated through the same large-scale clinical trials required for pharmaceutical treatments.
Comments